Merck Announces a New Covid PillBy Radiant Health
Published: October 3, 2021
Health News Briefs
The pharmaceutical company Merck announced it would soon seek emergency use authorization for its new pill, molnupiravir, to treat Covid-19. In studies conducted on people who recently contracted the virus, the experimental drug cut hospitalizations and deaths in half. The pill must be taken within five days of the appearance of symptoms, and it did not appear to help those who are already severely ill.
Download your free digital edition of Radiant at radianthealthmag.com/free.
- Bone Broth: Mother Nature’s Botox? - October 17, 2021
- A New Option for Early Breast Cancer Treatment - October 17, 2021
- New Recommendations for Low-Dose Aspirin Use - October 17, 2021
- FDA Advisory Panel Recommends Moderna and J & J Covid Vaccine Booster - October 17, 2021
- Study Indicates Covid Boosters Are Safe to Mix and Match - October 17, 2021
- Dementia Could be Related to Depression - October 10, 2021
- Family of Black Woman Whose Cells Were Used for Research Without Permission Files Law Suit - October 10, 2021
- Recall for At-Home Rapid Covid Test Kits - October 10, 2021
- WHO Approves First Malaria Vaccine - October 10, 2021
- Merck Announces a New Covid Pill - October 3, 2021